Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interferons: current status and future directions of this prototypic biological.

× No keyword cloud information.

60 in total

1. Interferons and cancer: how the promise is being kept.

Authors: E C Borden
Journal: Interferon Date: 1983

2. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors: M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal: Proc Natl Acad Sci U S A Date: 1982-05 Impact factor: 11.205

Review 3. Interferon-alpha: current status and future promise.

Authors: E M Bonnem; R J Spiegel
Journal: J Biol Response Mod Date: 1984-12

4. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.

Authors: E C Borden; T F Hogan; J G Voelkel
Journal: Cancer Res Date: 1982-12 Impact factor: 12.701

5. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors: T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal: Proc Natl Acad Sci U S A Date: 1984-08 Impact factor: 11.205

6. Positive interactions between interferon and chemotherapy due to direct tumor action rather than effects on host drug-metabolizing enzymes.

Authors: F R Balkwill; S Mowshowitz; S S Seilman; E M Moodie; D B Griffin; K H Fantes; C R Wolf
Journal: Cancer Res Date: 1984-11 Impact factor: 12.701

7. Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial.

Authors: E C Borden; J F Holland; T L Dao; J U Gutterman; L Wiener; Y C Chang; J Patel
Journal: Ann Intern Med Date: 1982-07 Impact factor: 25.391

8. Human leukocyte interferon produced by E. coli is biologically active.

Authors: D V Goeddel; E Yelverton; A Ullrich; H L Heyneker; G Miozzari; W Holmes; P H Seeburg; T Dull; L May; N Stebbing; R Crea; S Maeda; R McCandliss; A Sloma; J M Tabor; M Gross; P C Familletti; S Pestka
Journal: Nature Date: 1980-10-02 Impact factor: 49.962

9. Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.

Authors: E T Creagan; D L Ahmann; S J Green; H J Long; S Frytak; J R O'Fallon; L M Itri
Journal: J Clin Oncol Date: 1984-09 Impact factor: 44.544

10. In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells.

Authors: M Namba; S Yamamoto; H Tanaka; T Kanamori; M Nobuhara; T Kimoto
Journal: Cancer Date: 1984-11-15 Impact factor: 6.860

3 in total

Review 1. Immunogenetics.

Authors: K Bender
Journal: Experientia Date: 1986-10-15

2. Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.

Authors: A M Liberati; M Horisberger; M Schippa; F Di Clemente; M Fizzotti; S Filippo; M G Proietti; S Arzano; P Berruto; L Palmisano
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

3. Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells.

Authors: A M Otto
Journal: J Cancer Res Clin Oncol Date: 1994 Impact factor: 4.553

3 in total